Telomir Pharmaceuticals, Inc. (Ticker: TELO) is a pre-clinical-stage biopharmaceutical company based in Baltimore, Maryland, dedicated to advancing innovative therapeutic solutions targeting human stem cell disorders. The company is focused on harnessing proprietary technologies to develop novel treatments that have the potential to improve health outcomes in regenerative medicine. With a strong emphasis on research and development, Telomir aims to position itself at the forefront of stem cell therapy, addressing significant unmet medical needs and creating value for stakeholders as it moves toward commercialization.
Click "Analyze" to generate stock analysis
TELO Price Trend and Signals
TELO Financials
2025-10-21Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-09Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-09Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-09Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.